Marketing-authorisation holder
Sigillata Limited
5 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
5 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ATLIMARBAIGel | Diclofenac | Italy | Authorised | |
| DEFERASIROX SIGILLATACompressa dispersibile | Deferasirox | Italy | Authorised | |
| NELEDIADENCompressa rivestita con film | Atorvastatin | Italy | Authorised | |
| SYKURZUKICompressa rivestita con film | Metformin | Italy | Authorised | |
| TEKISIPPISCompressa rivestita con film | Paroxetine | Italy | Authorised |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Italy | 5 | 5 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Drugs used in diabetesAlimentary tract and metabolism · ATC A10B
- Lipid-modifying agentsCardiovascular system · ATC C10A
- Topical products for joint and muscular painMusculo-skeletal system · ATC M02A
- PsychoanalepticsNervous system · ATC N06A
- All other therapeutic productsVarious · ATC V03A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- sigillata
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 5
- Countries
- 1
- Roles
- Authorisation holder